Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 2,265.00
-35.00 (-1.52%)
Aug 11, 2026, 1:00 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 1.04 trillion as of August 10, 2026. Its market cap has increased by 18.82% in one year.
Market Cap
1.04T
Enterprise Value
1.03T
Revenue
299.67B
Ranking
n/a
PE Ratio
18.81
Stock Price
2,265.00
ChartMarket Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 1.04T, an increase of 104,114.96%. That is a compound annual growth rate of 29.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 1.04T | 7.82% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.20T |
| Cipla | 1.18T |
| Zydus Lifesciences | 1.11T |
| Mankind Pharma | 1.01T |
| Laurus Labs | 995.66B |
| Aurobindo Pharma | 953.98B |
| Alkem Laboratories | 671.96B |
| Glenmark Pharmaceuticals | 643.16B |